To explore the associations among cancer survivorship discussions, patient-physician expectations, and receipt of follow-up care in cancer survivors.

We surveyed cancer survivors about various aspects of their care, including expectations of their providers' roles, whether discussions with a physician had occurred, and self-reported patterns of follow-up. Primary care providers (PCPs) and oncologists were also surveyed for their own perceived roles. We developed a scoring system to evaluate the level of agreement in expectations between patients and physicians and between PCPs and oncologists (where 0 = most discordant and 4 = most concordant). Regression and stratified analyses were conducted to examine the relationships among expectations, discussions, and follow-up.

In total, 535 patients (54%) and 378 physicians (62%) responded. Survivorship care expectations were most discrepant between PCPs and oncologists (mean score, 1.78), moderate between patients and oncologists (mean score, 1.97), and most similar between patients and PCPs (mean score, 2.82). Having a conversation specifically about cancer follow-up was associated with better concordance between patients and oncologists, but not for patients and their PCPs or between physicians. Better concordance in patient-oncologist expectations also correlated with greater odds of receiving certain aspects of follow-up care, such as influenza vaccinations and physical examinations, but only if a discussion about cancer follow-up had occurred.

A discussion about cancer follow-up may affect survivorship care through its primary influence on patient-oncologist expectations. Further work is required to clarify the aspects of survivorship discussions that are important for optimal cancer survivorship care planning.

Advances in early detection and treatment strategies for various cancers, along with the aging general population, suggest that the number of cancer survivors will continue to increase steadily.13 Survivors face numerous difficulties, including psychosocial distress and physical ailments that may last for many years after diagnosis and treatment,46 highlighting the importance of developing survivorship care programs that can effectively address their short- and long-term needs. We previously reported that expectations for cancer survivorship care were highly discrepant between patients and their physicians and between primary care providers (PCPs) and oncologists, underscoring the potential complexities of delivering consistent survivorship care.7 Increasing time constraints among physicians and persistent disparities in health care access among patients may present additional challenges to providing comprehensive care for survivors. While this knowledge has strengthened our understanding of the different needs of survivors and improved our awareness of potential health care system barriers, few studies have formally examined possible solutions to these problems or evaluated interventions to optimize care.811

Communication between healthcare providers and patients is a cornerstone for fostering healthy patient-physician rapport, building mutual trust and respect, and establishing common goals and expectations for medical care. For early-stage cancers, discussions between patients and physicians have been found to be highly correlated with patients' satisfaction level, treatment choices, and overall quality of care.12,13 Likewise, in the palliative care setting, end-of-life discussions have been shown to be associated with earlier hospice referrals, lower health care costs, and more appropriate medical care near death.14,15 To date, research has yet to explore the impact of similar discussions on the expectations for and quality of cancer survivorship care. This type of information, however, is valuable and can help to inform survivors and their physicians and contribute to improving cancer survivorship care for the future.

We conducted self-administered surveys to assess patient and physician expectations for cancer survivorship care. In this analysis of the survey, we explored the associations among cancer survivorship discussions, patient-physician expectations, and the receipt of follow-up care. Because discussions may offer survivors and their physicians the opportunity to better define their goals for the medical care they should receive, we hypothesized that expectations may be more concordant between survivors and their physicians and between physicians themselves and that follow-up care may be more appropriate when a patient-physician conversation surrounding cancer survivorship has occurred.

Study Overview

This study was conducted between May 2006 and August 2007 after receiving approval from the institutional review board at Dana-Farber Cancer Institute in Boston, MA. Details of the survey design have been described previously.7 Briefly, two separate, complementary, self-administered questionnaires were developed using the modified Delphi approach; one was designed for patients and the other for physicians. The questionnaires were primarily devised to compare expectations for cancer survivorship care between patients and their physicians and between PCPs and oncologists and to determine patients' self-reported patterns of cancer follow-up care.

The patient survey was distributed to adult, English-speaking cancer survivors who were identified as having at least one component of their cancer management occur at Dana-Farber/Brigham and Women's Cancer Center in Boston, MA, still alive at two or more years after their original cancer diagnosis, and currently cancer free and not undergoing any active cancer treatments. The survey asked cancer survivors to identify a PCP and an oncologist whom they viewed as being most responsible for the ongoing care of their cancer. The physician version of the survey was subsequently sent to these providers. All eligible patients and physicians were mailed a package containing a letter that introduced the study and invited their voluntary participation, a copy of the patient or physician questionnaire, a small monetary incentive of US$2.00, and a postage-paid envelope for returning the completed survey. A consent form was included in the patient packages, which was to be completed by patients and then returned with the questionnaire, while the receipt of a completed physician survey implied informed consent.

Patient and Physician Questionnaires

In addition to baseline demographics and cancer-related clinical information, the patient questionnaire asked respondents to indicate the level of responsibility that their PCP or oncologist should take with regard to four important survivorship domains: (1) follow-up of their primary cancer, (2) screening of other cancers, (3) general preventive health, and (4) management of other comorbidities. Physicians were subsequently asked in their version of the survey to indicate their own perceived roles in the same four key survivorship areas. Responses to these questions on both the patient and physician questionnaires were evaluated on a 5-point Likert scale that reflected the perceived degree of physician responsibility (“none,” “a little,” “some,” “a lot,” and “full”). In the patient survey only, participants were also asked whether a discussion about cancer follow-up (eg, “Did you and your doctor ever have a discussion about who would follow you for your most recent cancer?”) or general medical care (“Did you and your doctor ever have a discussion about who would handle your other medical problems besides your cancer, such as diabetes, high blood pressure, or arthritis?”) had occurred with a physician. Furthermore, we inquired about the pattern of follow-up care that patients received in the past 12 months, including the receipt of influenza vaccinations, physical examinations, routine blood tests, and routine imaging studies.

Statistical Considerations

Descriptive statistics were used to summarize baseline demographic data and clinical characteristics of respondents. Surveys from patients were matched with those of their self-identified PCPs and oncologists to form patient-PCP and patient-oncologist pairs, respectively. Patients without a corresponding physician survey were not included in the matched analyses. Similarly, among patients with both a PCP and an oncologist survey, responses from PCPs were matched with those of the corresponding oncologists to form PCP-oncologist pairs. Concordance/discordance in expectations for the four survivorship areas was assessed for each group of matched survey pairs. For patient-PCP and patient-oncologist pairs, concordance was defined as complete agreement in Likert response categories, whereas discordance was signified by any disagreement in response categories between respondents of a matched survey pair. For PCP-oncologist pairs, however, responses that represented a potential duplication of medical services (ie, both physicians indicating “substantial” responsibility for a task) or omission of medical services (ie, both physicians claiming “minimal” responsibility for a task) were considered to be discordant. If both physicians responded that they had “some” degree of responsibility, this was not considered discordant since survivorship care tasks can be shared.

For this analysis specifically, we developed a composite scoring system that would allow for an overall assessment of cancer survivorship care expectations. For each of the four survivorship domains, a score of 0 was assigned when expectations were discordant and a score of 1 was given when expectations were concordant. A composite concordance score (CCS) was derived by summing the individual scores from each of the four survivorship areas, thus yielding a possible total CCS that ranged from a minimum of 0 (most discordant) to a maximum of 4 (most concordant). Considering the narrow range of the CCS, we conducted two-sample t tests to compare means in order to assess (1) the relationship between patient-physician discussion status (occurred v did not occur) and CCS and (2) the association between CCS and receipt of follow-up care. Multivariable logistic regression models, with CCS as the dependent variable, were subsequently constructed, which included all available patient factors and physician characteristics, regardless of significance on univariate testing. We developed additional multivariable logistic models, with receipt of follow-up care (yes/no) as the dependent variable, that were stratified by patient-physician discussion status to determine whether the effect of CCS on receipt of follow-up care was modified by discussions about cancer survivorship. All tests were two-sided and a P value < .05 was considered statistically significant. SAS 9.1.3 (SAS Institute, Cary, NC) was used for all statistical analyses.

Characteristics of Respondents

Table 1 summarizes the baseline demographics and clinical characteristics of the cancer survivor and physician cohorts. In total, 535 patients and 378 physicians completed the survey (response rates were 54% and 62%, respectively). Among patients, 104 (19%) indicated they were either currently not cancer free or still receiving active cancer treatments. Therefore, these cases were excluded, leaving 431 patient surveys (81%) eligible for analysis. Within this patient cohort, females, breast cancer survivors, white patients, high-income earners, and those who were married, obtained some postsecondary level education, and reported good health were more highly represented. For physicians, 255 (67%) were PCPs and 123 (33%) were oncologists. Among them, there were more community than academic practitioners. Overall, there were 409 matched patient-oncologist survey pairs, 233 patient-PCP pairs, and 232 PCP-oncologist pairs. Nonrespondents who formally opted out of survey participation did not differ significantly from respondents with respect to all demographic features.

Table

Table 1. Baseline Clinical Characteristics of Patient and Physician Respondents and Self-Reported Patterns of Cancer Survivorship Care

Table 1. Baseline Clinical Characteristics of Patient and Physician Respondents and Self-Reported Patterns of Cancer Survivorship Care

Characteristic Survey Respondents
No. %
Patient variables (n = 431)
    Age, years
        Median 57
        Range 16-91
    Sex
        Male 117 27
        Female 314 73
    Cancer site
        Breast 223 52
        Lung 17 4
        Gastrointestinal 28 6
        Genitourinary 37 9
        Gynecologic 18 4
        Hematologic 40 9
        Head and neck 31 7
        Other 16 4
        Unreported 21 5
    Marital status
        Single 46 11
        Married 320 74
        Separated/divorced 65 15
    Education
        Less than 8th grade 4 1
        Some high school 11 3
        High school graduation 60 14
        Some university 82 19
        University graduation 106 25
        Graduate school 166 39
        Unreported 2 0.5
    Race
        Black 10 2
        Asian 7 2
        White 406 94
        Multiracial 2 0.5
        Other 6 1
    Income, $
        < 20,000 23 6
        20,000-39,000 39 9
        40,000-59,000 41 10
        60,000-79,000 49 12
        > 80,000 199 48
        Unreported 80 15
    Ever smoker
        Yes 200 47
        No 229 52
        Unreported 2 1
    General health
        Poor 5 1
        Fair 24 6
        Good 112 26
        Very good 187 44
        Excellent 99 23
        Unreported 4 1
Physician variables (n = 378)
    Age, years
        Median 50
        Range 31-79
    Sex
        Male 239 63
        Female 139 37
    Practice
        Academic 156 41
        Community 222 59
    Specialty
        Primary care 255 67
        Oncology 123 33
Measures of cancer survivorship care (n = 431)
    Discussion about cancer follow-up*
        With oncologist 135 31
        With PCP 15 4
        Both 145 34
        Neither 74 17
        Unreported 62 14
    Discussion about general medical care*
        With oncologist 33 8
        With PCP 88 20
        Both 101 23
        Neither 145 34
        Unreported 64 15
    Flu vaccination
        Yes 288 33
        No 142 67
        Unreported 1 0.5
    Routine physical examinations
        Yes 382 89
        No 49 11
    Routine blood tests
        Yes 258 60
        No 173 40
    Routine imaging studies
        Yes 282 65
        No 149 35

Abbreviation: PCP, primary care provider.

*Discussion between patient and physician.

†In the preceding year.

Survivorship Care Patterns

The mean CCS between patients and PCPs and between patients and oncologists were 2.82 and 1.97, respectively, consistent with our prior report showing that expectations of patient-PCP pairs for each of the four key survivorship care domains were generally more concordant than those of patient-oncologist pairs.7 The observed agreement between PCPs and oncologists was lowest, with a mean CCS of only 1.78. Patients' self-reported patterns of cancer survivorship care are highlighted in Table 1. In total, 17% and 34% indicated that they failed to talk with at least one of their doctors about their cancer follow-up and general medical care, respectively. For the majority of patients who described having a survivorship discussion, cancer follow-up conversations occurred more frequently with oncologists while conversations about general medical care tended to involve PCPs. Most patients reported undergoing routine physical examinations, blood tests, and imaging studies in the past 12 months. However, most did not report receiving an influenza vaccination within the same time period. The mean number of visits to PCPs was 2.01 (standard deviation, 1.53) and to oncologists was 2.43 (standard deviation, 1.49) during the preceding year.

Discussion and Follow-Up and Their Association With Survivorship Expectations

Bivariate analyses of the relationships between survivorship discussions and concordance of expectations and the association between these expectations and follow-up care are described in Tables 2 and 3, respectively. Compared with no discussion, having a conversation about cancer follow-up was associated with a statistically significant higher mean CCS between patients and oncologists (2.05 v 1.78; P = .01). No additional relationships between discussion of different aspects of care and CCS were significant. In general, a higher CCS correlated with receipt of follow-up care. This was seen for patient-oncologist expectations where better concordance was significantly associated with receiving influenza vaccinations (P = .01), physical examinations (P = .01), and imaging studies (P = .03). Of note, a higher CCS between PCPs and oncologists was associated with the lack of routine blood tests (P = .01). Importantly, we did not observe any clear, consistent associations to support the notion that discussions were associated with follow-up care.

Table

Table 2. Association Between Mean Concordance Scores and Survivorship Care Discussions

Table 2. Association Between Mean Concordance Scores and Survivorship Care Discussions

Survey Pair Discussion About Cancer Follow-Up
P* Discussion About General Medical Care
P*
Occurred
Did Not Occur
Occurred
Did Not Occur
Mean SD Mean SD Mean SD Mean SD
Patient/oncologist (n = 409) 2.05 1.01 1.78 0.94 .01 1.99 0.99 1.95 1.00 .67
Patient/PCP (n = 233) 2.81 0.92 2.84 1.13 .82 2.77 1.07 2.88 0.90 .40
PCP/oncologist (n = 232) 1.71 1.12 1.93 1.08 .17 1.73 1.08 1.84 1.14 .46

Abbreviations: SD, standard deviation; PCP, primary care physician.

*P value based on two-sample t tests.

Table

Table 3. Association Between Mean Concordance Scores and Receipt of Follow-Up Care

Table 3. Association Between Mean Concordance Scores and Receipt of Follow-Up Care

Survey Pair Flu Vaccination
Physical Examination
Laboratory Tests
Imaging Studies
Yes No P* Yes No P* Yes No P* Yes No P*
Patient/oncologist (n = 409) 2.14 1.89 .01 2.02 1.54 .01 1.99 1.94 .61 2.05 1.82 .03
Patient/PCP (n = 233) 2.83 2.79 .78 2.83 2.69 .52 2.76 2.91 .25 2.86 2.75 .40
PCP/oncologist (n = 232) 1.79 1.75 .84 1.80 1.53 .30 1.52 2.13 .01 1.94 1.70 .11

Abbreviation: PCP, primary care physician.

*P value based on two-sample t tests.

Our multivariable analysis continued to demonstrate similar relationships, which are illustrated in Tables 4 and 5. Individuals reporting a discussion about cancer follow-up showed increasing odds of concordant patient-oncologist expectations. Likewise, a high CCS between patients and oncologists remained predictive of influenza vaccinations and routine physical examinations. We also explored possible patient and physician determinants for the presence of a survivorship discussion as well as for the receipt of follow-up care. While there was some suggestion that patients who were older, non-white, and poorer were less likely to have a survivorship discussion and less inclined to receive follow-up care, none achieved consistent statistical significance. In addition, we examined concordance of expectations for each of the four survivorship domains separately and their individual relationships with discussion and follow-up, but we were unable to identify any clear, consistent correlations. Finally, in an exploratory analysis of the patient-oncologist pairs only (Table 6), we stratified our model by discussion status. It appears that the impact of concordant patient-oncologist expectations on influenza vaccinations and physical examinations was observed only for those in whom a discussion about cancer follow-up had occurred.

Table

Table 4. Multivariable Analysis of CCS and Survivorship Care Discussions

Table 4. Multivariable Analysis of CCS and Survivorship Care Discussions

CCS Discussion About Cancer Follow-Up
Discussion About General Medical Care
OR 95% CI P* OR 95% CI P*
Patient/oncologist
    0 1.00 1.00
    1 1.40 1.04 to 1.88 .02 1.09 0.85 to 1.41 .49
    2 1.95 1.08 to 3.52 1.20 0.72 to 1.98
    3 2.73 1.13 to 6.60 1.31 0.61 to 2.80
    4 3.81 1.18 to 12.4 1.43 0.52 to 3.94
Patient/PCP
    0 1.00 1.00
    1 0.96 0.64 to 1.28 .84 0.87 0.61 to 1.25 .46
    2 0.92 0.41 to 2.07 0.76 0.37 to 1.56
    3 0.89 0.27 to 2.98 0.67 0.23 to 1.95
    4 0.85 0.17 to 4.29 0.58 0.14 to 2.44
PCP/oncologist
    0 1.00 1.00
    1 0.87 0.66 to 1.13 .29 0.93 0.73 to 1.19 .57
    2 0.75 0.44 to 1.28 0.87 0.53 to 1.42
    3 0.65 0.29 to 1.45 0.81 0.38 to 1.70
    4 0.56 0.19 to 1.64 0.75 0.28 to 2.02

Abbreviations: CCS, composite concordance score; OR, odds ratio; PCP, primary care physician.

*P value based on multivariable logistic regression, adjusted for patient and physician characteristics listed in Table 1.

Table

Table 5. Multivariable Analysis of CCS and Likelihood of Receiving Survivorship Care

Table 5. Multivariable Analysis of CCS and Likelihood of Receiving Survivorship Care

CCS Flu Vaccination
Physical Examination
Laboratory Tests
Imaging Studies
OR 95% CI P* OR 95% CI P* OR 95% CI P* OR 95% CI P*
Patient/oncologist .01 .03 .52 .13
    0 1.00 1.00 1.00 1.00
    1 1.38 1.03 to 1.84 1.66 1.17 to 2.37 1.11 0.82 to 1.49 1.26 0.92 to 1.55
    2 1.90 1.07 to 3.39 2.77 1.36 to 5.62 1.22 0.67 to 2.23 1.58 0.95 to 2.39
    3 2.62 1.10 to 6.24 4.60 1.59 to 13.3 1.35 0.55 to 3.32 1.99 0.97 to 3.71
    4 3.61 1.14 to 11.5 7.65 1.85 to 31.6 1.49 0.45 to 4.96 2.50 0.99 to 5.73
Patient/PCP .29 .68 .49 .58
    0 1.00 1.00 1.00 1.00
    1 1.26 0.82 to 1.92 1.15 0.58 to 1.73 1.16 0.77 to 1.75 0.89 0.58 to 1.36
    2 1.58 0.67 to 3.69 1.33 0.34 to 2.98 1.34 0.59 to 3.06 0.79 0.34 to 1.84
    3 1.98 0.55 to 7.08 1.53 0.20 to 5.14 1.55 0.45 to 5.36 0.70 0.20 to 2.49
    4 2.49 0.45 to 13.6 1.76 0.12 to 8.87 1.79 0.34 to 9.39 0.62 0.11 to 3.37
PCP/oncologist .66 .45 < .01 .14
    0 1.00 1.00 1.00 1.00
    1 1.06 0.81 to 1.39 1.19 0.76 to 1.86 0.57 0.43 to 0.76 0.82 0.63 to 1.06
    2 1.13 0.66 to 1.93 1.41 0.58 to 3.46 0.33 0.19 to 0.57 0.67 0.40 to 1.13
    3 1.20 0.53 to 2.68 1.68 0.44 to 6.43 0.19 0.08 to 0.43 0.55 0.25 to 1.21
    4 1.27 0.43 to 3.73 2.00 0.33 to 11.9 0.11 0.04 to 0.33 0.45 0.16 to 1.28

Abbreviations: CCS, composite concordance score; OR, odds ratio; PCP, primary care physician.

*P value based on multivariable logistic regression, adjusted for patient and physician characteristics listed in Table 1.

Table

Table 6. Effect of Discussion About Follow-Up on the Association Between CCS and Survivorship Care

Table 6. Effect of Discussion About Follow-Up on the Association Between CCS and Survivorship Care

CCS Flu Vaccination
Physical Examination
Laboratory Tests
Imaging Studies
Occurred
Did Not Occur
Occurred
Did Not Occur
Occurred
Did Not Occur
Occurred
Did Not Occur
OR 95% CI P* OR 95% CI P* OR 95% CI P* OR 95% CI P* OR 95% CI P* OR 95% CI P* OR 95% CI P* OR 95% CI P*
Patient/oncologist < .01 .86 .02 .11 .90 .33 .14 .13
    0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0
    1 1.68 1.16 to 1.91 0.97 0.65 to 1.43 1.86 1.11 to 3.09 1.49 0.91 to 2.44 0.98 0.68 to 1.42 1.21 0.83 to 1.76 1.20 0.94 to 1.54 1.35 0.92 to 2.00
    2 2.83 1.35 to 3.66 0.93 0.43 to 2.05 3.44 1.24 to 9.57 2.23 0.83 to 5.97 0.95 0.46 to 2.00 1.45 0.68 to 3.09 1.45 0.88 to 2.37 1.83 0.84 to 4.01
    3 4.77 1.57 to 7.00 0.90 0.28 to 2.93 6.39 1.38 to 29.6 3.33 0.76 to 14.6 0.93 0.31 to 2.83 1.75 0.57 to 5.43 1.74 0.83 to 3.66 2.48 0.77 to 8.02
    4 8.03 1.82 to 13.4 0.87 0.18 to 4.19 11.9 1.53 to 91.6 4.98 0.70 to 35.6 0.91 0.21 to 4.01 2.11 0.47 to 9.55 2.10 0.78 to 5.64 3.35 0.70 to 16.0

Abbreviations: CCS, composite concordance score; OR, odds ratio.

*P value based on multivariable logistic regression, adjusted for patient and physician characteristics listed in Table 1.

It is estimated that there are over 10 million cancer survivors in the United States, and this segment of the population is expected to continue to grow.16 A landmark report published by the Institute of Medicine17 highlighted the diverse array of physical and psychosocial issues associated with cancer survivorship and underscored its importance as a research priority. However, there are concerns that many of these survivorship issues are frequently overlooked by the health care system.18,19 We previously reported that expectations for survivorship care differed between patients and their physicians, and that a lack of clarity surrounding their respective roles may contribute to suboptimal levels of care.7 A few studies have described interventions to improve future survivorship care planning, but none have explored the role of patient-physician communication.811 We analyzed surveys from cancer survivors and their providers and found that patient-physician discussions were associated with greater agreement in some survivorship care expectations and that concordance in these expectations was in turn correlated with a higher propensity for certain aspects of follow-up.

While we originally hypothesized that patients whose views on survivorship care are best aligned with those of their physicians are more likely to receive appropriate care, our stratified model confirmed this association to be true only for patients who reported having a conversation about cancer survivorship with their physician. In the absence of such a discussion, concordance in expectations failed to correlate with follow-up. In fact, there was a nonsignificant trend for possibly less care (eg, fewer influenza vaccinations). One interpretation of this finding is that similarities in patient-physician expectations by themselves are insufficient for ensuring survivorship care. Our multivariable and stratified analyses in Tables 5 and 6, respectively, suggest that a patient-physician discussion may contribute to survivorship care planning by acting indirectly through its primary influence on patient-physician expectations. Discussions about cancer follow-up appear to modify the effect of concordant expectations on survivorship care, which is consistent with prior reports demonstrating a positive impact of patient-physician communication on clinical decision making and coordination of care across various clinical settings in oncology.1215

Importantly, discussions mainly posed a positive effect on patient-oncologist expectations and not on patient-PCP or PCP-oncologist expectations. The mean CCS between patients and their oncologists was moderate when compared with those of the other matched pairs, proposing that relationships in which expectations were already mostly discordant or mostly concordant may be less susceptible to the effect of a patient-physician discussion. Another reason for this difference is that survivors may come to view their oncologists as their primary provider of healthcare and medical advice, considering the unique patient-physician rapport that often develops during and after cancer treatment. In support of this hypothesis, we observed that it was only discussions about cancer follow-up, which occurred more frequently between patients and oncologists, that resulted in more congruent expectations and increased receipt of certain follow-up care. Because this was a cross-sectional survey, we were unable to delineate the directionality of events. Therefore, we cannot exclude the possibility that individuals with lower CCS at the outset were the ones in whom personal motivations were also the strongest to seek formal discussions with their doctors. We are also uncertain of the reasons why some aspects of follow-up were unaltered by concordant expectations or the presence of patient-physician discussions. The performance of blood tests and imaging studies typically requires more coordination between physicians and other healthcare workers (eg, laboratory and radiology technicians), and thus may be less amenable to behavioral interventions, such as survivorship discussions. Alternately, these aspects of care may necessitate multidisciplinary interventions in order to alter their patterns of use.

There are several limitations to our study. First, we surveyed a geographically localized group of patients and physicians, and we analyzed only successfully returned questionnaires. Additionally, our sample consisted largely of white, well-educated, female breast cancer patients who may have had expectations for survivorship care that varied considerably from those in different demographic groups. For these reasons, our results may not be completely generalizable to other centers, nonrespondents, minorities, or survivors across different cancer types. Second, survivorship care patterns were based on patients' self-report only and were susceptible to recall bias. These data were neither corroborated by their providers nor verified by medical record review. Furthermore, we did not collect information regarding the context in which follow-up interventions were given, so we could not determine whether procedures, such as vaccinations, were administered to survivors for the appropriate clinical indications. Moreover, other important survivorship care areas, such as psychosocial and vocational issues, were not considered in the CCS. Third, each physician completed the questionnaire only once, and their questions were not directed to the care of a particular patient, but to any of their patients who might be a cancer survivor. Therefore, it is possible that some responses might have been different if they were answering about a specific patient. Fourth, we dichotomized survivorship care discussion into whether one was reported to have occurred or not. Survivorship care discussions between patients and physicians are likely quite complex and dynamic, and future work should focus on aspects of these discussions, such as content, format, and delivery, which may impact their overall effectiveness on survivorship care planning. Finally, we focused our analyses on evaluating statistically significant differences in CCS between matched survey pairs without considering clinically meaningful differences. Symptom and quality-of-life analyses in oncology have typically used a minimum difference of 5% between matched pairs as a threshold for clinical meaningfulness.2022 Because the CCS was created specifically for this analysis and it has not been used previously, whether this same definition can be applied to survivorship research warrants further study.

In summary, cancer survivorship care is likely driven by multiple factors. Our study findings provide preliminary support to suggest that survivorship care discussions may increase some aspects of follow-up care through a primary influence on patient-oncologist expectations. Which elements within these discussions are most important and whether they foster truly appropriate follow-up care will require more in-depth evaluations in prospective, longitudinal studies. Further research should work toward developing models for facilitating patient-physician discussions that would best promote and optimize care for future cancer survivors.

© 2010 by American Society of Clinical Oncology

Supported by funds from the Perini Family Cancer Survivors' Center, an award from the Canadian Association of Medical Oncologists, and a grant from the National Cancer Institute of Canada.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

The author(s) indicated no potential conflicts of interest.

Conception and design: Winson Y. Cheung, Craig C. Earle

Financial support: Craig C. Earle

Administrative support: Craig C. Earle

Provision of study materials or patients: Craig C. Earle

Collection and assembly of data: Winson Y. Cheung, Bridget A. Neville

Data analysis and interpretation: Winson Y. Cheung, Bridget A. Neville

Manuscript writing: Winson Y. Cheung, Craig C. Earle

Final approval of manuscript: Winson Y. Cheung, Bridget A. Neville, Craig C. Earle

1. A Jemal, R Siegel, E Ward , etal: Cancer statistics, 2009 CA Cancer J Clin 59: 225249,2009 Crossref, MedlineGoogle Scholar
2. A Jemal, MJ Thun, LA Ries , etal: Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control J Natl Cancer Inst 100: 16721694,2008 Crossref, MedlineGoogle Scholar
3. T Kinsey, A Jemal, J Liff , etal: Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001 J Natl Cancer Inst 100: 10031012,2008 Crossref, MedlineGoogle Scholar
4. C Foster, D Wright, H Hill , etal: Psychosocial implications of living 5 years or more following a cancer diagnosis: A systematic review of the research evidence Eur J Cancer Care (Engl) 18: 223247,2009 Crossref, MedlineGoogle Scholar
5. BE Meyerowitz, K Kurita, LM D'Orazio: The psychological and emotional fallout of cancer and its treatment Cancer J 14: 410413,2008 Crossref, MedlineGoogle Scholar
6. BR Ferrell, KH Dow, S Leigh , etal: Quality of life in long-term cancer survivors Oncol Nurs Forum 22: 915922,1995 MedlineGoogle Scholar
7. WY Cheung, BA Neville, DB Cameron , etal: Comparisons of patient and physician expectations for cancer survivorship care J Clin Oncol 27: 24892495,2009 LinkGoogle Scholar
8. MC Morey, DC Snyder, R Sloane , etal: Effects of home-based diet and exercise on functional outcomes among older, overweight long-term cancer survivors: RENEW—A randomized controlled trial JAMA 301: 18831891,2009 Crossref, MedlineGoogle Scholar
9. I Korstjens, AM May, E van Weert , etal: Quality of life after self-management cancer rehabilitation: A randomized controlled trial comparing physical and cognitive-behavioral training versus physical training Psychosom Med 70: 422429,2008 Crossref, MedlineGoogle Scholar
10. RL Osborn, AC Demoncada, M Feuerstein: Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: Meta-analyses Int J Psychiatry Med 36: 1334,2006 Crossref, MedlineGoogle Scholar
11. W Demark-Wahnefried, EC Clipp, MC Morey , etal: Lifestyle intervention development study to improve physical function in older adults with cancer: Outcomes from Project LEAD J Clin Oncol 24: 34653473,2006 LinkGoogle Scholar
12. JY Chen, ML Tao, D Tisnado , etal: Impact of physician-patient discussions on patient satisfaction Med Care 46: 11571162,2008 Crossref, MedlineGoogle Scholar
13. W Liang, CB Burnett, JH Rowland , etal: Communication between physicians and older women with localized breast cancer: Implications for treatment and patient satisfaction J Clin Oncol 20: 10081016,2002 LinkGoogle Scholar
14. B Zhang, AA Wright, HA Huskamp , etal: Health care costs in the last week of life: Associations with end-of-life conversations Arch Intern Med 169: 480488,2009 Crossref, MedlineGoogle Scholar
15. AA Wright, B Zhang, A Ray , etal: Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment JAMA 300: 16651673,2008 Crossref, MedlineGoogle Scholar
16. Cancer survivorship research: About cancer survivorship—US prevalence estimates National Cancer Institute http://dccps.nci.nih.gov/ocs/about-survivorship.html Google Scholar
17. M Hewitt, S Greenfield, E Stovall: From Cancer Patient to Cancer Survivor: Lost in Transition 2006 Washington, DC Committee on Cancer Survivorship, Improving Care and Quality of Life, National Cancer Policy Board, Institute of Medicine, and National Research Council, National Academies Press Google Scholar
18. CC Earle, BA Neville: Under use of necessary care among cancer survivors Cancer 101: 17121719,2004 Crossref, MedlineGoogle Scholar
19. CC Earle, HJ Burstein, EP Winer , etal: Quality of non-breast cancer health maintenance among elderly breast cancer survivors J Clin Oncol 21: 14471451,2003 LinkGoogle Scholar
20. J Ringash, B O'Sullivan, A Bezjak , etal: Interpreting clinically significant changes in patient reported outcomes Cancer 110: 196202,2007 Crossref, MedlineGoogle Scholar
21. D Osoba, G Rodrigues, J Myles , etal: Interpreting the significance of changes in health-related quality-of-life scores J Clin Oncol 16: 139144,1998 LinkGoogle Scholar
22. B Barrett, D Brown, M Mundt , etal: Sufficiently important difference: Expanding the framework of clinical significance Med Decis Making 25: 250261,2005 Crossref, MedlineGoogle Scholar

COMPANION ARTICLES

No companion articles

ARTICLE CITATION

DOI: 10.1200/JCO.2009.26.4549 Journal of Clinical Oncology 28, no. 15 (May 20, 2010) 2577-2583.

Published online April 20, 2010.

PMID: 20406932

ASCO Career Center